Skip to content

Van Daele - Devroey

Active
Private limited companyfounded 2009active for 17 yearsAffligemdreef 143, 9300 Aalst, BelgiumKBO/BCE: BE 0816.576.583
Summary

Van Daele - Devroey has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €791,073 and a net result of €74,889. Equity has been growing by about 31% per year since 2018. Its solvency ranks better than 95% of 20,720 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Overview

Official details

Source: KBO
Status
Active since 30-06-2009 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.179.712.734 9300 Aalst, since 25-06-2009
Financial year end
31 December
Peppol
Reachable since 02-12-2025

Board and ownership

Board
  • Devroey PaulDirector · since 12-12-2023
  • Van Daele ChristineDirector · since 12-12-2023

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€115,261
▲ 2.6%
Turnover
≈ €210,000
estimated
Profit
€74,889
▲ 38.1%
Equity
€791,073
▲ 10.5%
Total assets
€800,361
▲ 10.3%
Score breakdownlowers riskLiquidity: current ratio 85.38, cash €698,256Sector: Human health activities (NACE 86)Equity €791,073 (98.8% of total assets)Size: total assets €800,361Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 64% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 98.8% of total assets
Liquidity 100=
short-term debt 1.2% · cash 87.2%
Profitability 80+2
return on assets 9.4%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,173 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025highest value 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €75,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 85.38 (77.58 in 2024), above the usual 1.5. Short-term debt is 1.2% and cash 87.2% of total assets. 1.2% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 27% on profitability and 53% on growth.

The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Liquidity: current ratio 85.38, cash €698,256
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Equity €791,073 (98.8% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €800,361
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-07-2026, 14 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
14 days early
2024
18 days late
2023
30 days early
2022
4 days early
2021
30 days early
2020
4 days early
2019
27 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 5 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 17 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
05-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Financials

Financials · financial year 2025, micro format

Annual accounts 2025 filed on 17-07-2026 at the NBB all 16 filings

Turnover
≈ €210,000
Estimated: probably between €180,000 and €280,000
Total assets
€800,361▲ 10.3%
2024 · €725,366
Net result
€74,889▲ 38.1%
2024 · €54,223
Working capital
€783,762▲ 11.5%
2024 · €703,178
Multi-year overview
2018 to 2025, 8 financial years
Operating result
€106,732
▲ 16.5% 2025
20182025
Net result
€74,889
▲ 38.1% 2025
middle half of the sector
20182025
Equity
€791,073
▲ 10.5% 2025
highest quarter of the sector
20182025
Total assets
€800,361
▲ 10.3% 2025
highest quarter of the sector
20182025
Debt
€9,288
▲ 1.2% 2025
20182025
Working capital
€783,762
▲ 11.5% 2025
highest quarter of the sector
20182025
Solvency
98.8%
▲ 0.1pp 2025
highest quarter of the sector
20182025
Current ratio
85.38
▲ 7.80 2025
highest quarter of the sector
20182025
Return on assets (ROA)
9.4%
▲ 1.9pp 2025
lowest quarter of the sector
20182025
Staff (FTE)
no figure
2025
20182025
Every figure per financial year
Every figure with its change against the financial year before
favourable unfavourable
Line20182019202020212022202320242025
Operating result€17,904-€188,356▲ 952%€171,640▼ 8.9%€235,774▲ 37.4%€133,752▼ 43.3%€37,993▼ 71.6%€91,592▲ 141%€106,732▲ 16.5%
Net result€18,683-€132,303▲ 608%€146,768above the sector's middle half▲ 10.9%€158,904above the sector's middle half▲ 8.3%€88,131within the sector's middle half▼ 44.5%€22,669within the sector's middle half▼ 74.3%€54,223within the sector's middle half▲ 139%€74,889within the sector's middle half▲ 38.1%
Equity€121,225-€252,715▲ 108%€392,257above the sector's middle half▲ 55.2%€551,161above the sector's middle half▲ 40.5%€639,291above the sector's middle half▲ 16.0%€661,961above the sector's middle half▲ 3.5%€716,184above the sector's middle half▲ 8.2%€791,073above the sector's middle half▲ 10.5%
Total assets€131,625-€493,157▲ 275%€589,151within the sector's middle half▲ 19.5%€722,884above the sector's middle half▲ 22.7%€705,114above the sector's middle half▼ 2.5%€691,535above the sector's middle half▼ 1.9%€725,366above the sector's middle half▲ 4.9%€800,361above the sector's middle half▲ 10.3%
Debt€10,400-€240,442▲ 23×€196,894▼ 18.1%€171,723▼ 12.8%€65,822▼ 61.7%€29,574▼ 55.1%€9,182▼ 69.0%€9,288▲ 1.2%
Working capital€121,225--€34,836€171,221within the sector's middle half€397,842above the sector's middle half▲ 132%€541,804above the sector's middle half▲ 36.2%€643,006above the sector's middle half▲ 18.7%€703,178above the sector's middle half▲ 9.4%€783,762above the sector's middle half▲ 11.5%
Solvency92.1%-51.2%▼ 40.9pp66.6%within the sector's middle half▲ 15.3pp76.2%within the sector's middle half▲ 9.7pp90.7%above the sector's middle half▲ 14.4pp95.7%above the sector's middle half▲ 5.1pp98.7%above the sector's middle half▲ 3.0pp98.8%above the sector's middle half▲ 0.1pp
Current ratio12.66-0.86▼ 11.801.87within the sector's middle half▲ 1.013.32within the sector's middle half▲ 1.459.23above the sector's middle half▲ 5.9122.74above the sector's middle half▲ 13.5177.58above the sector's middle half▲ 54.8485.38above the sector's middle half▲ 7.80
Return on assets (ROA)14.2%-26.8%▲ 12.6pp24.9%above the sector's middle half▼ 1.9pp22.0%within the sector's middle half▼ 2.9pp12.5%within the sector's middle half▼ 9.5pp3.3%below the sector's middle half▼ 9.2pp7.5%below the sector's middle half▲ 4.2pp9.4%below the sector's middle half▲ 1.9pp
Staff (FTE)1within the sector's middle half
above within below The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.

The operating result for 2025 is 17% higher than in 2024 and the highest since 2022. It is the second rise in a row, after the fall in 2023.

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €800,361
Fixed assets €7,312 ▼ 43.8%
Current assets €793,050 ▲ 11.3%
Equity and liabilities €800,361
Equity €791,073 ▲ 10.5%
Debt €9,288 ▲ 1.2%
Debt's share of the balance-sheet total falls from 1.3% to 1.2%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€112,427▲
2024 · €110,320
Cash flow
€80,584▲
2024 · €72,950
Debt to equity
0.01▼
2024 · 0.01
ROE
9.5%▲
2024 · 7.6%
Interest coverage
86.06▲
2024 · 76.58
Debt ≤ 1 year
€9,288▲
2024 · €9,182
Income taxes
€37,351▲
2024 · €36,370
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.

Investments

fixed assets acquired
Item20212022202320242025
Tangible fixed assets€2,898€22,089€2,628€12,779-
Financial fixed assets----€0
Depreciation and write-downs of the year€70,615€77,921€81,161€18,727€5,695

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 43 lines
Balance sheet Code20242025
Assets
Total assets20/58€725,366€800,361▲
Fixed assets21/28€13,006€7,312▼
Intangible fixed assets21€0-
Tangible fixed assets22/27€13,006€7,312▼
Plant, machinery and equipment23€5,806€3,446▼
Furniture and vehicles24€7,201€3,866▼
Current assets29/58€712,360€793,050▲
Amounts receivable within one year40/41€25,829€6,101▼
Trade receivables40€0-
Other amounts receivable41€25,829€6,101▼
Current investments50/53€72,566€72,566=
Cash at bank and in hand54/58€598,638€698,256▲
Deferred charges and accrued income490/1€15,326€16,127▲
Equity and liabilities
Total equity and liabilities10/49€725,366€800,361▲
Equity10/15€716,184€791,073▲
Contributions10/11€12,400€12,400=
Reserves13€596,199€671,089▲
Distributable reserves133€596,199€671,089▲
Profit (loss) carried forward14€107,585€107,585=
Amounts payable17/49€9,182€9,288▲
Amounts payable within one year42/48€9,182€9,288▲
Current portion of amounts payable after more than one year42€0-
Trade debts44€7,084€6,308▼
Suppliers440/4€7,084€6,308▼
Taxes, remuneration and social security45-€2,981
Taxes450/3-€2,981
Other amounts payable47/48€2,098€0▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€18,727€5,695▼
Other operating charges640/8€2,073€2,834▲
Gross operating margin9900€112,393€115,261▲
Operating profit (loss)9901€91,592€106,732▲
Financial income75/76B€441€6,814▲
Recurring financial income75€441€6,814▲
Financial charges65/66B€1,441€1,306▼
Recurring financial charges65€1,441€1,306▼
Profit (loss) for the period before taxes9903€90,593€112,240▲
Income taxes67/77€36,370€37,351▲
Profit (loss) for the period9904€54,223€74,889▲
Profit (loss) for the period to be appropriated9905€54,223€74,889▲
Appropriation of the result
Profit (loss) to be appropriated9906€161,808€182,474▲
Profit (loss) brought forward from the previous period14P€107,585€107,585=
Transfer to equity691/2€54,223€74,889▲
To other reserves6921€54,223€74,889▲

The notes to these accounts have 16 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 17-07-2026.

Line20182019202020212022202320242025Change
Remuneration, social security and pensions62---€40,570€24,705----
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€62,449€70,752€70,615€77,921€81,161€18,727€5,695▼ 69.6%
Other operating charges640/8---€3,761€3,443€3,211€2,073€2,834▲ 36.7%
Gross operating margin9900€19,549€288,167€287,694€350,721€239,821€122,365€112,393€115,261▲ 2.6%
Operating profit (loss)9901€17,904€188,356€171,640€235,774€133,752€37,993€91,592€106,732▲ 16.5%
Financial income75/76B---€313€534€120€441€6,814▲ 15×
Recurring financial income75€548€17€29,909€313€534€120€441€6,814▲ 15×
Financial charges65/66B---€942€1,280€2,545€1,441€1,306▼ 9.3%
Recurring financial charges65€290€522€692€942€1,280€2,545€1,441€1,306▼ 9.3%
Profit (loss) for the period before taxes9903€26,150€190,380€206,224€235,145€133,006€35,569€90,593€112,240▲ 23.9%
Income taxes67/77€7,467€58,077€59,456€76,242€44,876€12,899€36,370€37,351▲ 2.7%
Profit (loss) for the period9904€18,683€132,303€146,768€158,904€88,131€22,669€54,223€74,889▲ 38.1%
Profit (loss) for the period to be appropriated9905€18,683€132,303€146,768€158,904€88,131€22,669€54,223€74,889▲ 38.1%
Line20182019202020212022202320242025Change
Assets
Total assets20/58€131,625€493,157€589,151€722,884€705,114€691,535€725,366€800,361▲ 10.3%
Formation expenses20---€0€0€0---
Fixed assets21/28-€287,551€221,036€153,319€97,487€18,954€13,006€7,312▼ 43.8%
Intangible fixed assets21-€287,551€217,511€148,824€80,136€11,448€0--
Tangible fixed assets22/27--€3,525€4,495€17,351€7,506€13,006€7,312▼ 43.8%
Plant, machinery and equipment23----€7,915€2,402€5,806€3,446▼ 40.6%
Furniture and vehicles24---€4,495€9,436€5,104€7,201€3,866▼ 46.3%
Current assets29/58€131,625€205,606€368,115€569,565€607,627€672,581€712,360€793,050▲ 11.3%
Amounts receivable within one year40/41-€13,290€3,029€597€39,669€103,996€25,829€6,101▼ 76.4%
Trade receivables40---€597€4,545€12,650€0--
Other amounts receivable41---€0€35,124€91,346€25,829€6,101▼ 76.4%
Current investments50/53€94,258€94,258€72,566€72,566€72,566€72,566€72,566€72,566=
Cash at bank and in hand54/58€34,337€96,210€289,569€491,396€489,817€491,507€598,638€698,256▲ 16.6%
Deferred charges and accrued income490/1---€5,006€5,575€4,512€15,326€16,127▲ 5.2%
Equity and liabilities
Total equity and liabilities10/49€131,625€493,157€589,151€722,884€705,114€691,535€725,366€800,361▲ 10.3%
Equity10/15€121,225€252,715€392,257€551,161€639,291€661,961€716,184€791,073▲ 10.5%
Contributions10/11€12,400€12,400-€12,400€12,400€12,400€12,400€12,400=
Reserves13€1,240€1,240€272,273€431,176€519,307€541,976€596,199€671,089▲ 12.6%
Non-distributable reserves130/1---€1,240€1,240----
Reserves not available under the articles1311---€1,240€1,240----
Distributable reserves133---€429,936€518,067€541,976€596,199€671,089▲ 12.6%
Profit (loss) carried forward14€107,585€239,075€107,585€107,585€107,585€107,585€107,585€107,585=
Amounts payable17/49€10,400€240,442€196,894€171,723€65,822€29,574€9,182€9,288▲ 1.2%
Amounts payable within one year42/48€10,400€240,442€196,894€171,723€65,822€29,574€9,182€9,288▲ 1.2%
Current portion of amounts payable after more than one year42---€16,787€23,498€23,637€0--
Trade debts44-€9,312€10,910€8,255€2,901€5,937€7,084€6,308▼ 11.0%
Suppliers440/4---€8,255€2,901€5,937€7,084€6,308▼ 11.0%
Taxes, remuneration and social security45---€16,688---€2,981-
Taxes450/3---€11,333---€2,981-
Remuneration and social security454/9---€5,355-----
Other amounts payable47/48---€129,993€39,423-€2,098€0▼ 100%
Line20182019202020212022202320242025Change
Profit (loss) for the period9904€18,683€132,303€146,768€158,904€88,131€22,669€54,223€74,889▲ 38.1%
+ Depreciation and write-downs630-€62,449€70,752€70,615€77,921€81,161€18,727€5,695▼ 69.6%
Operating cash flow (approximation)€18,683€194,751€217,519€229,519€166,051€103,830€72,950€80,584▲ 10.5%
Investment in fixed assets (approximation)---€4,237-€2,898-€22,089-€2,628-€12,779€0-
Change in cash-€61,873€193,359€201,828-€1,580€1,690€107,131€99,618▼ 7.0%

A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.

Download as CSV

Historical observation

In July 2024, 17,811 companies had the same profile as Van Daele - Devroey has now. Two years later, 96.5% were still going and 0.3% had gone bankrupt.

  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
96.5% was still going
3.1% stopped otherwise
0.3% went bankrupt

That fits the bankruptcy probability of Van Daele - Devroey itself: < 0.1% within 12 months.

Test of the method

The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,811 companies, not a prediction for Van Daele - Devroey. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Latest 10 of 16 filings with the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 17-07-2026 2026-00304421 PDF
31-12-2024 micro format 18-08-2025 2025-00379490 PDF
31-12-2023 micro format 01-07-2024 2024-00188322 PDF
31-12-2022 micro format 27-07-2023 2023-00306942 PDF
31-12-2021 micro format 01-07-2022 2022-20124903 PDF
31-12-2020 micro format 27-07-2021 2021-41200273 PDF
31-12-2019 micro format 27-08-2020 2020-46700304 PDF
31-12-2018 micro format 29-08-2019 2019-60800585 PDF
31-12-2017 micro format 01-08-2018 2018-43300040 PDF
31-12-2016 micro format 04-08-2017 2017-41500546 PDF

Show all 16 filings

Board & ownership

Directors

Directors
2 directors
Devroey Paul
Director · since 12-12-2023 · listed in the 2025 annual accounts, filed on 17-07-2026
Current
Van Daele Christine
Director · since 12-12-2023 · listed in the 2025 annual accounts, filed on 17-07-2026
Current
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Artikel 14. Externe vertegenwoordiging Iedere bestuurder afzonderlijk, ook wanneer er meerdere zijn, vertegenwoordigt de vennootschap jegens…”
deed of 27-12-2023

Owners and capital

Capital transactions

Capital over time
  1. 27-12-2023 Converted to available equity

Mandate history

2 people, 2 in office
Show
  • Board
Mandates per person, with start and end dates
Name Functions and periods
Devroey Paul
  • Director, from 12-12-2023 to date
Van Daele Christine
  • Director, from 12-12-2023 to date
See the board, name and registered office on a given date →

Articles of association

Board and representation

Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
“België of buitenland zoals oproeping, tenminste helft aanwezig of vertegenwoordigd,zoniet nieuwe vergadering over zelfde dagorde met…”

Capital, shares and profit

Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“1 procent per maand op schuldig gebleven koopprijs,begonnen maand geldt als volledige maand, definitief gebonden alleen wanneer alle…”
Membership ruleThe articles set who can become a member or partner, and on what terms.
“Aandelen – Aandeelhouders - Aansprakelijkheid, deontologische geschillen voor bevoegde Provinciale Raden van Orde van Artsen”

Articles of association, deed of 27-12-2023 (in Dutch)

Network & group

Van Daele - Devroey shares no director with another company.

Companies at the same address

1 other company

Connections & network

2 current directors
Depth

The network starts from the directors of Van Daele - Devroey. Every other company they run is a node.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

Timeline

Deeds, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
17-07
NBB filing Annual accounts 2025 filedNBB
micro format · 14 days before the deadline
2025
18-08
NBB filing Annual accounts 2024 filedPDF
micro format · 18 days late
2024
31-12
Financial Liquidity more than triplescurrent ratio 77.58
The current ratio rises from 22.74 to 77.58. Short-term debt falls from €29,574 to €9,182.
01-07
NBB filing Annual accounts 2023 filedPDF
micro format · 30 days before the deadline
2023
31-12
Financial Liquidity more than doubledcurrent ratio 22.74
The current ratio rises from 9.23 to 22.74. Short-term debt falls from €65,822 to €29,574.
27-12
Gazette deed Legal-form change · Resignations & appointments
Board composition: Paul Devroey (director) · Board composition: Christine Van Daele (director)4 points ▸
  • General meeting, 12-12-2023
  • Registered office clause, Aalst, Affligemdreef 143
  • Board composition, Paul Devroey (director)
  • Board composition, Christine Van Daele (director)
  • The deed holds 3 more points.

Open the deed in the Belgian Official Gazette

27-07
NBB filing Annual accounts 2022 filedPDF
micro format · 4 days before the deadline
2022
31-12
Financial Liquidity more than doubledcurrent ratio 9.23
The current ratio rises from 3.32 to 9.23. Short-term debt falls from €171,723 to €65,822.
01-07
NBB filing Annual accounts 2021 filedPDF
micro format · 30 days before the deadline
2021
31-12
Financial Highest result from 2018 to 2025net €158,904 ▲8.3%
The operating result of €235,774 and the net result of €158,904 are both a record.
31-12
Financial Equity above €500,000equity €551,161 ▲40.5%
With a profit in every financial year since 2018, equity grows to €551,161.
27-07
NBB filing Annual accounts 2020 filedPDF
micro format · 4 days before the deadline
Show earlier events
2020
31-12
Financial Liquidity more than doubledcurrent ratio 1.87
The current ratio rises from 0.86 to 1.87. Short-term debt falls from €240,442 to €196,894.
27-08
NBB filing Annual accounts 2019 filedPDF
micro format · 27 days late
2019
31-12
Financial Equity above €200,000equity €252,715 ▲108%
With a profit in every financial year since 2018, equity grows to €252,715.
29-08
NBB filing Annual accounts 2018 filedPDF
micro format · 29 days late
2018
01-08
NBB filing Annual accounts 2017 filedPDF
micro format · 1 day late
2017
04-08
NBB filing Annual accounts 2016 filedPDF
micro format · 4 days late
2009
10-07
Gazette deed IncorporationPDF
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

Van Daele - Devroey was incorporated on 30 June 2009.1 Total assets rose from €131,625 in 2018 to €800,361 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Company details

Register details

Identity

KBO record
Name Van Daele - Devroey in Dutch
Enterprise number 0816.576.583
Legal form Private limited company
Status Active, normal situation
Founded 30-06-2009
Entity type Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 27-12-2023 (in Dutch)
Name clauseThe company operates under this name according to its articles.
Van Daele – Devroey
deed of 27-12-2023 (in Dutch)

Registered office and establishments

Registered office Affligemdreef 143, 9300 Aalst, Belgium
Establishment unit DUS.CONSULTING, Affligemdreef 143, 9300 Aalst since 25-06-2009 · unit number 2.179.712.734
Phone 053/780053 establishment in Aalst

Activities

NACEBEL 2025
86220 Specialist medical practice main activity
Codes under NACEBEL 2008
86220 Human health activities main activity
PurposeThe purpose describes the activities the company may carry out under its articles.
“De bevordering van geneeskunde door de stomatoloog-vennoten met inachtname van de medische plichtenleer. Alle medische activiteiten worden…”
12 activities
  1. De bevordering van geneeskunde door de stomatoloog-vennoten met inachtname van de medische plichtenleer. Alle medische activiteiten worden ingebracht in de vennootschap. De geneeskunde wordt uitgeoefend door een arts en onder zijn onbeperkte verantwoordelijkheid.
  2. De beoefening van de geneeskunde op het gebied van de gynaecologie, de verloskunde en de andrologie en gynaecologische oncologie, rekening houdende met de medische plichtenleer. Alle medische activiteiten worden ingebracht in de vennootschap. De geneeskunde wordt uitgeoefend door een arts en onder zijn onbeperkte verantwoordelijkheid.
  3. De honoraria betreffende de medische activiteiten en prestaties worden geïnd in naam en voor rekening van de vennootschap. Aan de artsen-vennoten wordt een vergoeding toegekend in verhouding tot de prestaties die hij voor rekening van de vennootschap geleverd heeft.
  4. Het bijdragen aan de ontwikkeling van de medische wetenschap algemeen met name door het verzorgen van lessen en voordrachten, verlenen van adviezen en uitgeven van publicaties.
  5. Advies aan medische en farmaceutische industrie.
  6. Het geven van lezingen en het uitgeven van medische boeken.
  7. Het stellen van onderzoekingen inzake medische vraagstukken.
  8. Het geven van opleidingen aan medici.
  9. Het opzetten en verrichten van klinische studies.
  10. Het nemen van patenten en octrooien.
  11. De aankoop, het huren en/of leasen van alle medische apparatuur en begeleidende accommodaties, inclusief gebouwen, kortom van een volledige materiële infrastructuur, om deze ter beschikking te stellen van derden.
  12. Het inrichten van algemene diensten en een medisch apparaat in het bijzonder, die rechtstreeks nuttig of nodig zijn voor de uitoefening van voormelde activiteit.
deed of 27-12-2023 (in Dutch)

Invoicing and payment

VAT number BE 0816.576.583
E-invoicing via Peppol
Reachable via Peppol
Peppol ID 0208:0816576583
Other Peppol ID 9925:BE0816576583
Registered 02-12-2025

Follow this company and you will hear the next morning if it leaves the Peppol register.

Register as of 5 November 2026 · Peppol Directory

Financial year and general meeting

Accounts at the NBB
Financial year end 31-12
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
30 June at 19:00
deed of 27-12-2023 (in Dutch)

Sites & property

Location
registered office establishment The establishment unit on the map
2 companies at this address See who is registered here

Buildings and parcels at the address

Ground area
1,605 m²
Building footprint
268 m²
Building volume
1,363 m³
Cadastral parcel Region Area Buildings Height / floors
41304G0235/00F000 Flanders 1,605 m² 1 · 268 m² 8.0 m · 2